Exemestane as Third and Fourth Line Hormonal Therapy for Metastatic Breast Cancer
Breast Cancer Research - United Kingdom
doi 10.1186/bcr-2000-66684
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2000
Authors
Publisher
Springer Science and Business Media LLC